Severity of airflow limitation is associated with severity of airway inflammation in smokers

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 4, 1998, Pages 1277-1285

  Di Stefano, Antonino ^a   Capelli, Armando ^b   Lusuardi, Mirco ^b   Balbo, Piero ^b   Vecchio, Cinzia ^b   Maestrelli, Piero ^b   Mapp, Cristina E ^b   Fabbri, Leonardo M ^b   Donner, Claudio F ^b   Saetta, Marina ^b  

^a IRCCS   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ADULT; AGED; ARTICLE; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NATURAL KILLER CELL; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION;

EID: 14444279391     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.4.9802078     Document Type: Article

References (33)

1. Fletcher, C., and R. Peto. 1977. The natural history of chronic airflow obstruction. B.M.J. 1:1645-1648.
2. Diener, C. F., and B. Burrows. 1975. Further observations on the course and prognosis of chronic obstructive lung disease. Am. Rev. Respir. Dis. 111:714-724.
3. Hogg, J. C., P. T. Macklem, and W. A. Thurlbeck. 1968. Site and nature of airway obstruction in chronic obstructive lung disease. N. Engl. J. Med. 278:1355-1360.
4. Snider, G. L. 1989. Changes in COPD occurrence: chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. Am. Rev. Respir. Dis. 140:S3-S8.
5. Saetta, M., A. Di Stefano, P. Maestrelli, A. Ferraresso, R. Drigo, A. Potena, A. Ciaccia, and L. M. Fabbri. 1993. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am. Rev. Respir. Dis. 147:301-306.
6. Di Stefano, A., P. Maestrelli, A. Roggeri, G. Turato, S. Calabro, A. Potena, C. E. Mapp, A. Ciaccia, L. Covacev, L. M. Fabbri, and M. Saetta. 1994. Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am. J. Respir. Crit. Care Med. 149:803-810.
7. Turato, G., A. Di Stefano, P. Maestrelli, C. E. Mapp, M. P. Ruggieri, A. Roggeri, L. M. Fabbri, and M. Saetta. 1995. Effect of smoking cessation on airway inflammation in chronic bronchitis. Am. J. Respir. Crit. Care Med. 152:1262-1267.
8. Di Stefano, A., G. Turato, P. Maestrelli, C. E. Mapp, M. Ruggieri, A. Roggeri, P. Boschetto, L. M. Fabbri, and M. Saetta. 1996. Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa. Am. J. Respir. Crit. Care Med. 153:629-632.
9. 1. Am. J. Respir. Crit. Care Med. 155:852-857.
10. Fournier, M., F. Lebargy, F. Le Roy Ladurie, E. Lenormand, and R. Pariente. 1989. Intraepithelial T-lymphocyte subsets in the airways of normal subjects and of patients with chronic bronchitis. Am. Rev. Respir. Dis. 140:737-742.
11. Ollerenshaw, S. L., and A. J. Woolcock. 1992. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. Am. Rev. Respir. Dis. 145:922-927.
12. Linden, M., J. B. Rasmussen, E. Piitulainen, A. Tunek, M. Larson, H. Tegner, P. Venge, L. A. Laitinen, and R. Brattsand. 1993. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am. Rev. Respir. Dis. 148:1226-1232.
13. Saetta, M., G. Turato, F. M. Facchini, L. Corbino, R. E. Lucchini, G. Casoni, P. Maestrelli, C. E. Mapp, A. Ciaccia, and L. M. Fabbri. 1997. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am. J. Respir. Crit. Care Med. 156:1633-1639.
14. Lacoste, J. Y., J. Bousquet, P. Chanez, T. Van Vyve, J. Simony-Lafontaine, N. Lequeu, P. Vic, I. Enander, P. Godard, and F. B. Michel. 1993. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 92:537-548.
15. Vignola, A. M., P. Chanez, G. Chiappara, A. Merendino, E. Pace, A. Rizzo, A. M. La Rocca, V. Bellia, G. Bonsignore, and J. Bousquet. 1997. Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am. J. Respir. Crit. Care Med. 156:591-599.
16. Adams, D. H., and A. R. Lloyd. 1997. Chemokines: leucocyte recruitment and activation cytokines. Lancet 349:490-495.
17. American Thoracic Society. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. (ATS statement). Am. J. Respir. Crit. Care Med. 152:577-8120.
18. Siafakas, N. M., P. Vermeire, N. B. Pride, P. Paoletti, J. Gibson, P. Howard, J. C. Yernault, M. Decramer, T. Higenbottam, D. S. Postma, and J. Rees. 1995. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur. Respir. J. 8:1398-1420.
19. Saetta, M., A. Di Stefano, P. Maestrelli, G. Turato, M. P. Ruggieri, A. Roggeri, P. Calcagni, C. E. Mapp, A. Ciaccia, and L. M. Fabbri. 1994. Airway eosinophilia in chronic bronchitis during exacerbations. Am. J. Respir. Crit. Care Med 150:1646-1652.
20. Thompson, A. B., D. Daughlon, R. A. Robbins, M. A. Ghafouri, M. Oehlerking, and S. I. Rennard. 1989. Intraluminal airway inflammation in chronic bronchitis: characterization and correlation with clinical parameters. Am. Rev. Respir. Dis. 140:1527-1537.
21. Communitè Europeennè du Carbon et de l'Acier. 1971. Aide-memoire of Spirographic Practice for Examining Ventilatory Function. 2nd ed. Industrial Health and Medicine, Luxemburg.
22. Baggiolini, M., D. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv. Immunol. 55:97-179.
23. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310.
24. Haley, K. J., and J. M. Drazen. 1998. Inflammation and airway function in asthma: what you see is not necessarily what you get. Am. J. Respir. Cru. Care Med. 157:1-3.
25. Taub, D. D., J. R. Ortaldo, S. M. Turcovski-Corrales, M. L. Key, D. L. Longo, and W. J. Murphy. 1996. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J. Leukoc. Biol. 59:81-89.
26. 2+ mobilization, and enzyme release. J. Immunol. 156:322-327.
27. Wilson, R. 1992. The pathogenesis and management of bronchial infections: the vicious circle of respiratory decline. Rev. Contemp. Pharmacother. 3:103-112.
28. Gura, T. 1996. Chemokines take center stage in inflammatory ills. Science 272:954-956.
29. Standiford, T. J., S. L. Kunkel, M. J. Greenberger, L. L. Laichalk, and R. M. Strieter. 1996. Expression and regulation of chemokines in bacterial pneumonia. J. Leukoc. Biol. 59:24-28.
30. Martin, T. R., G. Raghu, R. J. Maunder, and S. C. Springmeyer. 1985. The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage. Am. Rev. Respir. Dis. 132:254-260.
31. Lusuardi, M., A. Capelli, C. G. Cerutti, E. L. Spada, and C. F. Donner. 1994. Airways inflammation in subjects with chronic bronchitis who have never smoked. Thorax 49:1211-1216.
32. O'Shaughnessy, T. C., T. W. Ansari, N. C. Barnes, and P. K. Jeffery. 1996. Inflammatory cells in the airway surface epithelium of bronchitic smokers with and without airflow obstruction. Eur. Respir. J. 9:14s.
33. Wenzel, S. E., S. J. Szefler, D. Y. M. Leung, S. I. Sloan, M. D. Rex, and R. J. Martin. 1997. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am. J. Respir. Crit. Care Med. 156:737-743.